[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=87a9ecf66a100a2b6eecdbc30a4d132d91039fdfc13125aed1ac2778a9b0536d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742316120,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors",
      "id": 133245682,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=87a9ecf66a100a2b6eecdbc30a4d132d91039fdfc13125aed1ac2778a9b0536d"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals (REGN): Among the Best Biotech Stocks to Buy According to Billionaires",
    "summary": "We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other best biotech stocks. Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some of the industry’s companies […]",
    "url": "https://finnhub.io/api/news?id=098206ae429845699f38c4de898e175151c99e34dccc561c5e456017fffe9514",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742290681,
      "headline": "Regeneron Pharmaceuticals (REGN): Among the Best Biotech Stocks to Buy According to Billionaires",
      "id": 133325926,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other best biotech stocks. Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some of the industry’s companies […]",
      "url": "https://finnhub.io/api/news?id=098206ae429845699f38c4de898e175151c99e34dccc561c5e456017fffe9514"
    }
  },
  {
    "ts": null,
    "headline": "United States v. Regeneron: Where \"But-For\" Art Thou, Romeo?",
    "summary": "On February 18, the US Court of Appeals for the First Circuit issued its long-awaited decision in United States v. Regeneron Pharmaceuticals, Inc.1joining a high-profile circuit split on the extent of...",
    "url": "https://finnhub.io/api/news?id=c2a7d804c35479a5046f64ad829ea8a185e73b7d6a1fd5454bfebbb95b34aaae",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742278206,
      "headline": "United States v. Regeneron: Where \"But-For\" Art Thou, Romeo?",
      "id": 133215550,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "On February 18, the US Court of Appeals for the First Circuit issued its long-awaited decision in United States v. Regeneron Pharmaceuticals, Inc.1joining a high-profile circuit split on the extent of...",
      "url": "https://finnhub.io/api/news?id=c2a7d804c35479a5046f64ad829ea8a185e73b7d6a1fd5454bfebbb95b34aaae"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Wants You to ‘Own’ Regeneron Pharmaceuticals (REGN) Shares",
    "summary": "We recently published a list of Jim Cramer’s Latest Stock Moves: Top 10 Calls. In this article, we are going to take a look at where Regeneron Pharmaceuticals Inc (NASDAQ:REGN) stands against other stocks that Jim Cramer discusses. Jim Cramer in a recent program on CNBC expressed his frustration over the recent market selloff following […]",
    "url": "https://finnhub.io/api/news?id=7804706c157ae0e9954f323cc3a193b2b854f79a68251096dfdcc41bc7cd6ec4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742263623,
      "headline": "Jim Cramer Wants You to ‘Own’ Regeneron Pharmaceuticals (REGN) Shares",
      "id": 133325927,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer’s Latest Stock Moves: Top 10 Calls. In this article, we are going to take a look at where Regeneron Pharmaceuticals Inc (NASDAQ:REGN) stands against other stocks that Jim Cramer discusses. Jim Cramer in a recent program on CNBC expressed his frustration over the recent market selloff following […]",
      "url": "https://finnhub.io/api/news?id=7804706c157ae0e9954f323cc3a193b2b854f79a68251096dfdcc41bc7cd6ec4"
    }
  }
]